Amanote Research
Register
Sign In
Polymyxin B Hemoperfusion in High Endotoxin Activity Level Septic Shock Patients
Critical Care
- United Kingdom
doi 10.1186/cc6679
Full Text
Open PDF
Abstract
Available in
full text
Categories
Critical Care
Intensive Care Medicine
Date
January 1, 2008
Authors
G Monti
V Terzi
M Mininni
S Colombo
S Vesconi
G Casella
Publisher
Springer Science and Business Media LLC
Related search
Improved Outcome of Septic Shock Patients Treated Without Polymyxin B Hemoperfusion
Nihon Kyukyu Igakukai Zasshi
Endotoxin Removal by Hemoperfusion in Septic Shock
Critical Care
Critical Care
Intensive Care Medicine
Re-Evaluation of Direct Hemoperfusion With Polymyxin-B Immobilized Fiber for Severe Sepsis and Septic Shock
Critical Care
Critical Care
Intensive Care Medicine
The Effect of Endotoxin Adsorber Hemoperfusion on Microcirculation in Patients With Severe Sepsis and Septic Shock
Intensive Care Medicine Experimental
Critical Care
Intensive Care Medicine
Prevalence and Clinical Significance of Early Endotoxin Activity in Septic Shock Patients
Critical Care
Critical Care
Intensive Care Medicine
Sphingosine-1-Phosphate (S1P) Is a Feasible Biomarker in Predicting the Efficacy of Polymyxin B-Immobilized Fiber Direct Hemoperfusion (PMX-DHP) in Patients With Septic Shock
Journal of Nippon Medical School
Medicine
Correction To: Polymyxin B-Immobilized Hemoperfusion and Mortality in Critically Ill Adult Patients With Sepsis/Septic Shock: A Systematic Review With Meta-Analysis and Trial Sequential Analysis
Intensive Care Medicine
Critical Care
Intensive Care Medicine
Alteco Endotoxin Hemoadsorption in Gram-Negative Septic Shock Patients
Indian Journal of Critical Care Medicine
Critical Care
Intensive Care Medicine
Endotoxin Elimination in Patients With Septic Shock: An Observation Study
Archivum Immunologiae et Therapiae Experimentalis
Medicine
Allergy
Immunology
